Cases 1 - 10 of 119
SALIX PHARMACEUTICALS, INC. et al v. CARNEGIE PHARMACEUTICALS, LLC
as 2:2024cv07531
Plaintiff:
SALIX PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, LTD. and BAUSCH HEALTH IRELAND LTD.
Defendant:
CARNEGIE PHARMACEUTICALS, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH HEALTH IRELAND LIMITED et al v. MSN LABORATORIES PRIVATE LTD. et al
as 2:2024cv07182
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED and SALIX PHARMACEUTICALS, INC.
Defendant:
MSN LABORATORIES PRIVATE LTD. and MSN PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
SALIX PHARMACEUTICALS, INC. et al v. NORWICH PHARMACEUTICALS, INC. et al
as 3:2024cv07140
Plaintiff:
SALIX PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, LTD. and BAUSCH HEALTH IRELAND LTD.
Defendant:
NORWICH PHARMACEUTICALS, INC., ALVOGEN PB RESEARCH AND DEVELOPMENT LLC, ALVOGEN, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
SALIX PHARMACEUTICALS, INC. et al v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC et al
as 1:2024cv04607
Plaintiff:
SALIX PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, LTD., ALFASIGMA S.p.A. and others
Defendant:
AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, AMNEAL EU, LIMITED, AMNEAL PHARMACEUTICALS, LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00036
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
SALIX PHARMACEUTICALS, INC. et al v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC et al
as 3:2024cv04607
Plaintiff:
SALIX PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, LTD., ALFASIGMA S.p.A. and others
Defendant:
AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, AMNEAL EU, LIMITED, AMNEAL PHARMACEUTICALS, LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Norwich Pharmaceuticals, Inc. v. Xavier Becerra, et al
as 23-5311
Plaintiff:
Norwich Pharmaceuticals, Inc.
Defendant:
Xavier Becerra, in his official capacity as Secretary of Health and Human Services, Robert McKinnon Califf, M.D., in his official capacity as Commissioner of Food and Drugs and United States Food and Drug Administration
Intervenor:
Salix Pharmaceuticals, Inc.
CURIA IP HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD. et al
as 2:2023cv13764
Plaintiff:
CURIA IP HOLDINGS, LLC
Defendant:
SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., BAUSCH HEALTH COMPANIES, INC. and others
Cause Of Action: 28 U.S.C. § 1331 Fed. Question
CURIA HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD. et al
as 1:2023cv13764
Plaintiff:
CURIA HOLDINGS, LLC
Defendant:
SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., BAUSCH HEALTH COMPANIES, INC. and others
Cause Of Action: 28 U.S.C. § 1331 Fed. Question
CURIA HOLDINGS, LLC v. SALIX PHARMACEUTICALS, LTD. et al
as 3:2023cv13764
Plaintiff:
CURIA HOLDINGS, LLC
Defendant:
SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., BAUSCH HEALTH COMPANIES, INC. and others
Cause Of Action: 28 U.S.C. § 1331 Fed. Question
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
